...
首页> 外文期刊>Oncogenesis. >Epigenetic regulation of lung cancer cell proliferation and migration by the chromatin remodeling protein BRG1
【24h】

Epigenetic regulation of lung cancer cell proliferation and migration by the chromatin remodeling protein BRG1

机译:铬癌细胞增殖和染色质重塑蛋白BRG1的脑膜脑细胞增殖和迁移的表观遗传调节

获取原文
           

摘要

Malignant lung cancer cells are characterized by uncontrolled proliferation and migration. Aberrant lung cancer cell proliferation and migration are programmed by altered cancer transcriptome. The underlying epigenetic mechanism is unclear. Here we report that expression levels of BRG1, a chromatin remodeling protein, were significantly up-regulated in human lung cancer biopsy specimens of higher malignancy grades compared to those of lower grades. Small interfering RNA mediated depletion or pharmaceutical inhibition of BRG1 suppressed proliferation and migration of lung cancer cells. BRG1 depletion or inhibition was paralleled by down-regulation of cyclin B1 (CCNB1) and latent TGF-β binding protein 2 (LTBP2) in lung cancer cells. Further analysis revealed that BRG1 directly bound to the CCNB1 promoter to activate transcription in response to hypoxia stimulation by interacting with E2F1. On the other hand, BRG1 interacted with Sp1 to activate LTBP2 transcription. Mechanistically, BRG1 regulated CCNB1 and LTBP2 transcription by altering histone modifications on target promoters. Specifically, BRG1 recruited KDM3A, a histone H3K9 demethylase, to remove dimethyl H3K9 from target gene promoters thereby activating transcription. KDM3A knockdown achieved equivalent effects as BRG1 silencing by diminishing lung cancer proliferation and migration. Of interest, BRG1 directly activated KDM3A transcription by forming a complex with HIF-1α. In conclusion, our data unveil a novel epigenetic mechanism whereby malignant lung cancer cells acquired heightened ability to proliferate and migrate. Targeting BRG1 may yield effective interventional strategies against malignant lung cancers.
机译:恶性肺癌细胞的特征在于不受控制的增殖和迁移。异常肺癌细胞增殖和迁移由改变的癌症转录组进行编程。潜在的表观遗传机制尚不清楚。在这里,我们认为BRG1的表达水平,染色质重塑蛋白,与较低等级相比,在更高的恶性等级的人肺癌活检标本中明显上调。小干扰RNA介导的BRG1抑制或药物抑制BRG1抑制肺癌细胞的增殖和迁移。 BRG1耗竭或抑制通过在肺癌细胞中的细胞周期蛋白B1(CCNB1)和潜在的TGF-β结合蛋白2(LTBP2)的潜伏期调节并联。进一步的分析表明,BRG1直接与CCNB1启动子结合,以反应与E2F1相互作用的缺氧刺激来激活转录。另一方面,BRG1与SP1相互作用以激活LTBP2转录。通过改变目标启动子对组蛋白修饰改变组蛋白修饰来机械地,BRG1调节CCNB1和LTBP2转录。具体而言,BRG1募集KDM3A,组蛋白H3K9去甲基酶,以从靶基因启动子中除去二甲基H3K9,从而激活转录。通过减少肺癌增殖和迁移,KDM3A敲低实现了与BRG1沉默的相同效果。感兴趣的是,BRG1通过形成具有HIF-1α的复合物直接激活KDM3A转录。总之,我们的数据揭示了一种新型的表观遗传机制,恶性肺癌细胞获得了增殖和迁移的能力。靶向BRG1可能会产生针对恶性肺癌的有效介入策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号